PDZK1 regulates organic anion transporting polypeptide oatp1a in mouse small intestine

Drug Metabolism and Pharmacokinetics

Volumn 25, Issue 6, 2010, Pages 588-598

  Sugiura, Tomoko ^a   Otake, Toru ^a   Shimizu, Takuya ^a   Wakayama, Tomohiko ^a   Silver, David L ^b   Utsumi, Rie ^a   Nishimura, Tomohiro ^a   Iseki, Shoichi ^a   Nakamichi, Noritaka ^a   Kubo, Yoshiyuki ^a   Tsuji, Akira ^a   Kato, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Extrone 3 sulfate; Intestinal absorption; OATP; PDZ protein; PDZK1; Protein protein interactions; SLC transporters

Indexed keywords

ESTRONE SULFATE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER POLYPEPTIDE 1A; PDZ PROTEIN; POLYCLONAL ANTIBODY; PROTEIN PDZK1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; INHIBITION KINETICS; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SMALL INTESTINE;

EID: 78951490023     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-10-RG-074     Document Type: Article

References (43)

1. Jacqueminm, E., Hagenbuch, B., Stieger, B., Wolkoff, A. W. and Meier, P. J.: Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc. Natl. Acad. Sci. U.S.A., 91: 133-137 (1994).
2. Kullak-Ublick, G. A., Hagenbuch, B., Stieger, B., Schteingart, C. D., Hofmann, A. F., Wolkoff, A. W. and Meier, P. J.: Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology, 109: 1274-1282 (1995).
3. Abe, T., Kakyo, M., Tokui, T., Nakagomi, R., Nishio, T., Nakai, D., Nomura, H., Unno, M., Suzuki, M., Naitoh, T., Matsuno, S. and Yawo, H.: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J. Biol. Chem., 274: 17159-17163 (1999).
4. Tamai, I., Nezu, J., Uchino, H., Sai, Y., Oku, A., Shimane, M. and Tsuji, A.: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun., 273: 251-260 (2000).
5. Kobayashi, D., Nozawa, T., Imai, K., Nezu, J., Tsuji, A. and Tamai, I.: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J. Pharmacol. Exp. Ther., 306: 703-708 (2003).
6. Sai, Y., Kaneko, Y., Ito, S., Mitsuoka, K., Kato, Y., Tamai, I., Artursson, P. and Tsuji, A.: Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab. Dispos., 34: 1423-1431 (2006).
7. Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J. and Hagenbuch, B.: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology, 120: 525-533 (2001).
8. Nozawa, T., Imai, K., Nezu, J., Tsuji, A. and Tamai, I.: Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J. Pharmacol. Exp. Ther., 308: 438-445 (2004).
9. Glaeser, H., Bailey, D. G., Dresser, G. K., Gregor, J. C., Schwarz, U. I., McGrath, J. S., Jolicoeur, E., Lee, W., Leake, B. F., Tirona, R. G. and Kim, R. B.: Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther., 81: 362-370 (2007).
10. Dresser, G. K., Bailey, D. G., Leake, B. F., Schwarz, U. I., Dawson, P. A., Freeman, D. J. and Kim, R. B.: Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther., 71: 11-20 (2002).
11. Bailey, D. G., Dresser, G. K., Leake, B. F. and Kim, R. B.: Naringin is a major and selective clinical inhibitor of organic aniontransporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin. Pharmacol. Ther., 81: 495-502 (2007).
12. Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R. and Kim, R. B.: OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab. Dispos., 27: 866-871 (1999).
13. Satoh, H., Yamashita, F., Tsujimoto, M., Murakami, H., Koyabu, N., Ohtani, H. and Sawada, Y.: Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab. Dispos., 33: 518-523 (2005).
14. Lilja, J. J., Backman, J. T., Laitila, J., Luurila, H. and Neuvonen, P. J.: Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol. Clin. Pharmacol. Ther., 73: 192-198 (2003).
15. Lilja, J. J., Juntti-Patinen, L. and Neuvonen, P. J.: Orange juice substantially reduces the bioavailability of the beta-adrenergicblocking agent celiprolol. Clin. Pharmacol. Ther., 75: 184-190 (2004).
16. Lilja, J. J., Raaska, K. and Neuvonen, P. J.: Effects of grapefruit juice on the pharmacokinetics of acebutolol. Br. J. Clin. Pharmacol., 60: 659-663 (2005).
17. Lilja, J. J., Raaska, K., and Neuvonen, P. J.: Effects of orange juice on the pharmacokinetics of atenolol. Eur. J. Clin. Pharmacol., 61: 337-340 (2005).
18. Schwarz, U. I., Seemann, D., Oertel, R., Miehlke, S., Kuhlisch, E., Fromm, M. F., Kim, R. B., Bailey, D. G. and Kirch, W.: Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin. Pharmacol. Ther., 77: 291-301 (2005).
19. Kato, Y., Miyazaki, T., Kano, T., Sugiura, T., Kubo, Y. and Tsuji, A.: Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol. J. Pharm. Sci., 98: 2529-2539 (2009).
20. Shirasaka, Y., Kuraoka, E., Spahn-Langguth, H., Nakanishi, T., Langguth, P. and Tamai, I.: Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J. Pharmacol. Exp. Ther., 332: 181-189 (2010).
21. Kato, Y., Yoshida, K., Watanabe, C., Sai, Y. and Tsuji, A.: Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm. Res., 21: 1886-1894 (2004).
22. Kato, Y., Sai, Y., Yoshida, K., Watanabe, C., Hirata, T. and Tsuji, A. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol. Pharmacol., 67: 734-743 (2005).
23. Sugiura, T., Kato, Y., Kubo, Y. and Tsuji, A.: Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2. Drug Metab. Pharmacokinet., 21: 375-383 (2006).
24. Sugiura, T., Kato, Y., Wakayama, T., Silver, D.L., Kubo, Y., Iseki, S. and Tsuji, A.: PDZK1 regulates two intestinal solute carriers (Slc15a1 and Slc22a5) in mice. Drug Metab. Dispos., 36: 1181-1188 (2008).
25. Lan, D. and Silver, D. L.: Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1. J. Biol. Chem., 280: 23390-23396 (2005).
26. Wakayama, T., Kato, Y., Utsumi, R., Tsuji, A. and Iseki, S.: A time- and cost-saving method of producing rat polyclonal antibodies. Acta Histochem. Cytochem., 39: 79-87 (2006).
27. Nishimura, T., Amano, N., Kubo, Y., Ono, M., Kato, Y., Fujita, H., Kimura, Y. and Tsuji, A.: Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey. Drug Metab. Dispos., 35: 1275-1284 (2007).
28. Davies, B. and Morris, T.: Physiological parameters in laboratory animals and humans. Pharm. Res., 10: 1093-1095 (1993).
29. Kato, Y., Sugiura, M., Sugiura, T., Wakayama, T., Kubo, Y., Kobayashi, D., Sai, Y., Tamai, I., Iseki, S. and Tsuji, A.: Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol. Pharmacol., 70: 1-9 (2006).
30. Vanwert, A. L., Bailey, R. M. and Sweet, D. H.: Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am. J. Physiol. Renal Physiol., 293: F1332-F1341 (2007).
31. Cheng, X., Maher, J., Chen, C. and Klaassen, C. D.: Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps). Drug Metab. Dispos., 33: 1062-1073 (2005).
32. Walters, H. C., Craddock, A. L., Fusegawa, H., Willingham, M. C. and Dawson, P. A.: Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am. J. Physiol. Gastrointest. Liver Physiol., 279: G1188-G1200 (2000).
33. Nishimura, T., Kubo, Y., Kato, Y., Sai, Y., Ogihara, T. and Tsuji, A.: Characterization of the uptake mechanism for a novel loop diuretic, M17055, in Caco-2 cells: involvement of organic anion transporting polypeptide (OATP)-B. Pharm. Res., 24: 90-98 (2007).
34. Sato, T., Mushiake, S., Kato, Y., Sato, K., Sato, M., Takeda, N., Ozono, K., Miki, K., Kubo, Y., Tsuji, A., Harada, R. and Harada, A.: The Rab8 GTPase regulates apical protein localization in intestinal cells. Nature, 448: 366-369 (2007).
35. Broere, N., Chen, M., Cinar, A., Singh, A. K., Hillesheim, J., Riederer, B., Lunnemann, M., Rottinghaus, I., Krabbenhoft, A., Engelhardt, R., Rausch, B., Weinman, E.J., Donowitz, M., Hubbard, A., Kocher, O., de Jonge, H. R., Hogema, B. M. and Seidler, U.: Defective jejunal and colonic salt absorption and altered Na(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice. Pflugers Arch., 457: 1079-1091 (2009).
36. Li, M., Wang, W., Soroka, C. J., Mennone, A., Harry, K., Weinman, E. J. and Boyer, J. L.: NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function. J. Biol. Chem., 285: 19299-19307 (2010).
37. Fenske, S. A., Yesilaltay, A., Pal, R., Daniels, K., Barker, C., Quiñones, V., Rigotti, A., Krieger, M. and Kocher, O.: Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ dmains of PDZK1. J. Biol. Chem., 284: 5797-5806 (2009).
38. Hillesheim, J., Riederer, B., Tuo, B., Chen, M., Manns, M., Biber, J., Yun, C., Kocher, O. and Seidler, U.: Down regulation of small intestinal ion transport in PDZK1- (CAP70/NHERF3) deficient mice. Pflugers Arch, 454: 575-586 (2007).
39. Wang, P., Wang, J. J., Xiao, Y., Murray, J. W., Novikoff, P. M., Angeletti, R. H., Orr, G. A., Lan, D., Silver, D.L. and Wolkoff, A. W.: Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 on the hepatocyte surface. J. Biol. Chem., 280: 30143-30149 (2005).
40. Nishizato, Y., Ieiri, I., Suzuki, H., Kimura, M., Kawabata, K., Hirota, T., Takane, H., Irie, S., Kusuhara, H., Urasaki, Y., Urae, A., Higuchi, S., Otsubo, K. and Sugiyama, Y.: Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin. Pharmacol. Ther., 73: 554-565 (2003).
41. Niemi, M., Kivistoä, K. T., Hofmann, U., Schwab, M., Eichelbaum, M. and Fromm, M. F.: Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1). Br. J. Clin. Pharmacol., 59: 602-604 (2005).
42. Niemi, M., Backman, J. T., Kajosaari, L.I., Leathart, J. B., Neuvonen, M., Daly, A. K., Eichelbaum, M., Kivistö, K.T. and Neuvonen, P. J.: Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clin. Pharmacol. Ther., 77: 468-478 (2005).
43. Lamprecht, G., Gaco, V., Turner, J. R., Natour, D. and Gregor, M.: Regulation of the intestinal anion exchanger DRA (downregulated in adenoma). Ann. N.Y. Acad. Sci., 1165: 261-266 (2009).